Recurrent MGMT-Methylated Glioblastoma
Oncology
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Recurrent MGMT-Methylated Glioblastoma?
There are 1 clinical trial targeting Recurrent MGMT-Methylated Glioblastoma tracked by BioSniper.
What is the prevalence of Recurrent MGMT-Methylated Glioblastoma?
The estimated prevalence of Recurrent MGMT-Methylated Glioblastoma is approximately 3.2 per 100,000 population.
Deep-dive into Recurrent MGMT-Methylated Glioblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis